[Expression and clinical significance of circadian gene Per2 in non-small cell lung cancer].

Chuang Chi, Zhi feng He, Y. Liu, Xiao ming Lin, Cheng chao Sun

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

To detect the expression of Per2 in non-small cell lung cancer (NSCLC), and analyze its clinical significance. The expression of Per2 was determined in 60 NSCLC and 20 normal lung tissues by immunohistochemical assay, and the relationship between Per2 expression and clinicopathological features was analyzed. The positive expression rates of Per2 in NSCLC and normal lung tissues were 71.7% and 95.0%, respectively (P < 0.05). The expression of Per2 in NSCLC was correlated with pathological differentiation and TNM stage (P < 0.05). The expression of Per2 in NSCLC is decreased. The negative expression of Per2 may contribute to the development and invasion in NSCLC.

Original languageEnglish
Pages (from-to)129-131
Number of pages3
JournalChinese Journal of Oncology
Volume35
Issue number2
Publication statusPublished - Jan 1 2013
Externally publishedYes

Fingerprint

Neoplastic Gene Expression Regulation
Period Circadian Proteins
Lymphatic Metastasis
Neoplasm Grading
Neoplasm Staging
Non-Small Cell Lung Carcinoma
Lung Neoplasms
Smoking
Genes

ASJC Scopus subject areas

  • Medicine(all)

Cite this

[Expression and clinical significance of circadian gene Per2 in non-small cell lung cancer]. / Chi, Chuang; He, Zhi feng; Liu, Y.; Lin, Xiao ming; Sun, Cheng chao.

In: Chinese Journal of Oncology, Vol. 35, No. 2, 01.01.2013, p. 129-131.

Research output: Contribution to journalArticle

Chi, Chuang ; He, Zhi feng ; Liu, Y. ; Lin, Xiao ming ; Sun, Cheng chao. / [Expression and clinical significance of circadian gene Per2 in non-small cell lung cancer]. In: Chinese Journal of Oncology. 2013 ; Vol. 35, No. 2. pp. 129-131.
@article{2d0848134d6e4c05aed724d49af95f17,
title = "[Expression and clinical significance of circadian gene Per2 in non-small cell lung cancer].",
abstract = "To detect the expression of Per2 in non-small cell lung cancer (NSCLC), and analyze its clinical significance. The expression of Per2 was determined in 60 NSCLC and 20 normal lung tissues by immunohistochemical assay, and the relationship between Per2 expression and clinicopathological features was analyzed. The positive expression rates of Per2 in NSCLC and normal lung tissues were 71.7{\%} and 95.0{\%}, respectively (P < 0.05). The expression of Per2 in NSCLC was correlated with pathological differentiation and TNM stage (P < 0.05). The expression of Per2 in NSCLC is decreased. The negative expression of Per2 may contribute to the development and invasion in NSCLC.",
author = "Chuang Chi and He, {Zhi feng} and Y. Liu and Lin, {Xiao ming} and Sun, {Cheng chao}",
year = "2013",
month = "1",
day = "1",
language = "English",
volume = "35",
pages = "129--131",
journal = "Chinese Journal of Oncology",
issn = "0253-3766",
publisher = "Chinese Academy of Medical Sciences",
number = "2",

}

TY - JOUR

T1 - [Expression and clinical significance of circadian gene Per2 in non-small cell lung cancer].

AU - Chi, Chuang

AU - He, Zhi feng

AU - Liu, Y.

AU - Lin, Xiao ming

AU - Sun, Cheng chao

PY - 2013/1/1

Y1 - 2013/1/1

N2 - To detect the expression of Per2 in non-small cell lung cancer (NSCLC), and analyze its clinical significance. The expression of Per2 was determined in 60 NSCLC and 20 normal lung tissues by immunohistochemical assay, and the relationship between Per2 expression and clinicopathological features was analyzed. The positive expression rates of Per2 in NSCLC and normal lung tissues were 71.7% and 95.0%, respectively (P < 0.05). The expression of Per2 in NSCLC was correlated with pathological differentiation and TNM stage (P < 0.05). The expression of Per2 in NSCLC is decreased. The negative expression of Per2 may contribute to the development and invasion in NSCLC.

AB - To detect the expression of Per2 in non-small cell lung cancer (NSCLC), and analyze its clinical significance. The expression of Per2 was determined in 60 NSCLC and 20 normal lung tissues by immunohistochemical assay, and the relationship between Per2 expression and clinicopathological features was analyzed. The positive expression rates of Per2 in NSCLC and normal lung tissues were 71.7% and 95.0%, respectively (P < 0.05). The expression of Per2 in NSCLC was correlated with pathological differentiation and TNM stage (P < 0.05). The expression of Per2 in NSCLC is decreased. The negative expression of Per2 may contribute to the development and invasion in NSCLC.

UR - http://www.scopus.com/inward/record.url?scp=84886673620&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886673620&partnerID=8YFLogxK

M3 - Article

VL - 35

SP - 129

EP - 131

JO - Chinese Journal of Oncology

JF - Chinese Journal of Oncology

SN - 0253-3766

IS - 2

ER -